GOT1 and colorectal carcinoma: To further interrogate these metabolic differences, we also employed 13C-Glc and Gln tracing analyses following GOT1 knockdown in the PA-TU-8902 PDA and DLD-1 CRC lines (Additional file 1: Figures S5 and Figure S6, Additional file 2: Extended Table 1).